Status:
COMPLETED
Evaluation of Immune Signaling Networks in Healthy Human Volunteers
Lead Sponsor:
Martin Angst
Conditions:
Normal Immune Cell Function
Eligibility:
All Genders
18-50 years
Brief Summary
The purpose of this study is to better understand whether and to what extent the activity of immune cells in blood varies over time under normal conditions as assessed in healthy subjects. Results of ...
Eligibility Criteria
Inclusion
- Age 18-50
- Good general health
Exclusion
- Recent cold or flu
- Chronic use of medications affecting the immune system
- Chronic illness
- Smoking habit
- History of drug abuse
- Current recreational drug use
Key Trial Info
Start Date :
August 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT01882582
Start Date
August 1 2012
End Date
July 1 2013
Last Update
May 4 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Stanford, California, United States, 94305